KenjiPFujitaMD

Adult Congenital Heart Disease

Physician

Dr. Fujita is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
125 Paterson St
# Clinical
New Brunswick, NJ 08901
Phone+1 732-235-7112

Fax+1 732-235-7114

New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2005 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
Harvard Medical SchoolClass of 2000

PubMed

39 citations
Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension
Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P. Fujita
Neurology. 2021-01-26
213 citations
Integrin-Mediated Neutrophil Adhesion and Retinal Leukostasis in Diabetes
Fina Cañas Barouch, Kazuaki Miyamoto, Jennifer R. Allport, Kenji Fujita, Sven-Erik Bursell
Investigative Ophthalmology & Visual Science. 2000-04-01
77 citations
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study.
Christopher M. O'Connor, Mona Fiuzat, Carlo Lombardi, Kenji Fujita, Gang Jia
Circulation. Heart Failure. 2011-11-01

Gene Therapy Restores Vision in First-Ever Trial for Rare, Inherited Blindness Finds Lancet StudySeptember 6th, 2024
Atsena Therapeutics Announces Positive 6-Month Data from Ongoing Phase I/II Clinical Trial of ATSN-101 in Patients with Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (LCA1)April 25th, 2023
Atsena Therapeutics to Present Positive Interim Encore Data from the Phase I/II Clinical Trial of ATSN-101 for the Treatment of GUCY2D-Associated Leber Congenital Amaurosis (LCA1) at the 46th Annual Macula Society MeetingFebruary 8th, 2023
Join now to see all